Our Research Publications
Updated November 2023
Pagination
- Previous page
- Page 34
- Next page
Title | Authors | Year | Journal | Link to Article | Intended Audience Sort descending | Purpose |
---|---|---|---|---|---|---|
The importance of iron for whole blood donors: a Canadian perspective | Pambrun C, Goldman M | 2018 | Blood.ca website | View The importance of iron for whole blood donors: a Canadian perspective | Health care providers | Other |
Système Diego : l’anticorps anti-Wra | Meunier D, Peng S, Clarke G | 2019 | Blood.ca website | View Système Diego : l’anticorps anti-Wra | Health care providers | Benchmarking and standard setting |
Circulaire d'information utilisation de composants sanguins humains: Composants plasmatiques | Jenkins C | 2021 | Blood.ca website | Health care providers | Benchmarking and standard setting | |
Guide des pratiques exemplaires pour la gestion des réserves de sang | Clarke G, Romans R | 2020 | Blood.ca website | View Guide des pratiques exemplaires pour la gestion des réserves de sang | Health care providers | Benchmarking and standard setting |
A prospective multi-faceted interventional study of blood bank technologist screening of red blood cell transfusion orders: The START study | Kron AT, Collins A, Cserti-Gazdewich C, Pendergrast J, Webert K, Lieberman L, Zeller MP, Harding SR, Nahirniak S, Prokopchuk-Gauk O, Lin Y, Mendez B, Armali C, Lee C, Watson D, Arnott D, Xun F, Blain H, Panchuk H, Hughes H, Chorneyko K, Angers M, Pilutti N, Lett R, Dowsley S, Ruijs T, Cupido T, Kichinko T, Thompson T, Afshar-Ghotli Z, Callum J, University of Toronto Quality in Utilization, Education and Safety in Transfusion (QUEST) Research Program | 2021 | Transfusion | View A prospective multi-faceted interventional study of blood bank technologist screening of red blood cell transfusion orders: The START study | Health care providers | Clinical research |
Massive Hemorrhage Protocol: Quality Metrics Portal Pilot | Thompson T, Callum J | 2022 | Ontario Regional Blood Coordinating Network February 2022 Newsletter | View Massive Hemorrhage Protocol: Quality Metrics Portal Pilot | Health care providers | Clinical research |
International Forum on the Management of Major Haemorrhage: Responses | Green L, Stanworth S, McQuilten Z, Lin V, Tucker H, Jackson B, Badawi M, Hindawi S, Chaurasia R, Patidar G, Pandey HC, Fasola F, Miyata S, Matsumoto M, Matsushita T, Rahimi-Levene N, Peer V, Pavenski K, Callum J, Thompson T, Murphy M, Staves J, Maegele M, Abeyakoon C, Rushford K, Wood E, Nuñez MA, Mellado S, Saa E, Triyono T, Pratomo B, Apelseth TO, Dunbar N | 2022 | Vox Sang | View International Forum on the Management of Major Haemorrhage: Responses | Health care providers | Benchmarking and standard setting |
From MPOX to the next epidemic: Words matter when talking about equity-deserving groups | Butler-Foster T, Khandelwal A, Montemayor C, Miller YM, Yan MTS, Holmberg JA, Ipe TS, Accooe P, Cancelas JA | 2023 | Transfusion | View From MPOX to the next epidemic: Words matter when talking about equity-deserving groups | Health care providers | Ethical, legal & social implications research |
Plasma transfusion practices: A multicentre electronic audit | Khandelwal A, Minuk L, Liu Y, Arnold DM, Heddle NM, Barty R, Hsia C, Solh Z, Shehata N, Thompson T, Tinmouth A, Perelman I, Skeate R, Kron AT, Callum J | 2022 | Vox Sang | View Plasma transfusion practices: A multicentre electronic audit | Health care providers | Clinical research |
Serologic reactivity of unidentified specificity in antenatal testing and hemolytic disease of the fetus and newborn: The BEST collaborative study | Lu W, Ziman A, Yan MTS, Waters A, Virk MS, Tran A, Tang H, Shih AW, Scally E, Raval JS, Pandey S, Pagano MB, Shan H, Moore C, Morrison D, Cormack O, Fitzgerald J, Duncan J, Corean J, Clarke G, Yazer M | 2023 | Transfusion | View Serologic reactivity of unidentified specificity in antenatal testing and hemolytic disease of the fetus and newborn: The BEST collaborative study | Health care providers | Clinical research |
Chapter 14. Therapeutic apheresis | Oliver M, Patriquin C | 2023 | Clinical Guide to Transfusion | View Chapter 14. Therapeutic apheresis | Health care providers | Benchmarking and standard setting |
Circular of information for the use of human blood components: Whole Blood | Stewart T | 2022 | Blood.ca website | View Circular of information for the use of human blood components: Whole Blood | Health care providers | Benchmarking and standard setting |
A blinded study of bone marrow examinations in patients with primary immune thrombocytopenia | Mahabir VK, Ross C, Popovic S, Sur ML, Bourgeois J, Lim W, George JN, Wang G, Cook RJ, Toltl LJ, Nazi I, Kelton JG, Arnold DM | 2013 | Eur J Haematol | View A blinded study of bone marrow examinations in patients with primary immune thrombocytopenia | Health care providers | Clinical research |
Composants sanguins négatifs pour les anti-CMV, irradiés et lavés | Prokopchuk-Gauk O, Solh Z | 2017 | Guide de la pratique transfusionnelle | View Composants sanguins négatifs pour les anti-CMV, irradiés et lavés | Health care providers | Benchmarking and standard setting |
Evaluating the "family veto" of consent for organ donation | Toews M, Caulfield T | 2016 | CMAJ | View Evaluating the "family veto" of consent for organ donation | Health care providers | Other |
Fatal false-negative transfusion infection involving a buffy coat platelet pool contaminated with biofilm-positive Staphylococcus epidermidis: a case report | Kou Y, Pagotto F, Hannach B, Ramirez-Arcos S | 2015 | Transfusion | View Fatal false-negative transfusion infection involving a buffy coat platelet pool contaminated with biofilm-positive Staphylococcus epidermidis: a case report | Health care providers | Clinical research |
Outcomes of both abbreviated hyper-CVAD induction followed by autologous hematopoietic cell transplantation and conventional chemotherapy for mantle cell lymphoma: a 10-year single-centre experience with literature review | Alwasaidi TA, Hamadah A, Altouri S, Tay J, McDiarmid S, Faught C, Allan D, Huebsch L, Bredeson C, Bence-Bruckler I | 2015 | Cancer Med | View Outcomes of both abbreviated hyper-CVAD induction followed by autologous hematopoietic cell transplantation and conventional chemotherapy for mantle cell lymphoma: a 10-year single-centre experience with literature review | Health care providers | Clinical research |
Prothrombin complex concentrate for emergent reversal of warfarin: an international survey of hospital protocols | Gorlin J, Kinney S, Fung M, Tinmouth A | 2017 | Vox Sang | View Prothrombin complex concentrate for emergent reversal of warfarin: an international survey of hospital protocols | Health care providers | Clinical research |
Red Cell, Platelet and White Cell Antigens | Webert KE, Arnold DM, Chan HWH, Smith JW, Heddle NM, Kelton JG | 2013 | Wintrobe's Clinical Hematology | View Red Cell, Platelet and White Cell Antigens | Health care providers | Other |
The effects of lysine analogs during pelvic surgery: a systematic review and meta-analysis | Breau RH, Kokolo MB, Punjani N, Cagiannos I, Beck A, Niznick N, Buenaventura C, Cowan J, Knoll G, Momoli F, Morash C, Ruzicka M, Schachkina S, Tinmouth A, Xie HY, Fergusson DA | 2014 | Transfus Med Rev | View The effects of lysine analogs during pelvic surgery: a systematic review and meta-analysis | Health care providers | Clinical research |
Warfarin resumption following anticoagulant-associated intracranial hemorrhage: a systematic review and meta-analysis | Chai-Adisaksopha C, Iorio A, Hillis C, Siegal D, Witt DM, Schulman S, Crowther M | 2017 | Thromb Res | View Warfarin resumption following anticoagulant-associated intracranial hemorrhage: a systematic review and meta-analysis | Health care providers | Clinical research |
Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo?controlled trials | Bussel J, Arnold DM, Grossbard E, Mayer J, Treliski J, Homenda W, Hellmann A, Windyga J, Sivcheva L, Khalafallah AA, Zaja F, Cooper N, Markovtsov V, Zayed H, Duliege AM | 2018 | Am J Hematol | View Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo?controlled trials | Health care providers | Clinical research |
Management of iron deficiency | Ning S, Zeller MP | 2019 | Hematology Am Soc Hematol Educ Program | View Management of iron deficiency | Health care providers | Clinical research |
Réduction des agents pathogènes dans les produits de fractionnement | Bigham M | 2019 | Guide de la pratique transfusionnelle | View Réduction des agents pathogènes dans les produits de fractionnement | Health care providers | Benchmarking and standard setting |
Combination of two complementary automated rapid assays for diagnosis of heparin-induced thrombocytopenia (HIT) | Warkentin TE, Sheppard JI, Smith JW, Li N, Moore JC, Arnold DM, Nazy I | 2020 | J Thromb Haemost | View Combination of two complementary automated rapid assays for diagnosis of heparin-induced thrombocytopenia (HIT) | Health care providers | Clinical research |
An open-source python library for detection of known and novel Kell, Duffy and Kidd variants from exome sequencing | Montemayor C, Simone A, Long J, Montemayor O, Delvadia B, Rivera R, Lewis KL, Shahsavari S, Gandla D, Dura K, Krishnan US, Wendzel NC, Elavia N, Grissom S, Karagianni P, Bueno M, Loy D, Cacanindin R, McLaughlin S, Tynuv M, Brunker PAR, Roback J, Adams S, Smith H, Biesecker L, Klein HG | 2021 | Vox Sang | View An open-source python library for detection of known and novel Kell, Duffy and Kidd variants from exome sequencing | Health care providers | New or improved product or process |
Research Unit: Protecting patients with sickle cell disease from alloimmunization risk: benefits of genotyping | Shih AW | 2020 | Blood.ca website | View Research Unit: Protecting patients with sickle cell disease from alloimmunization risk: benefits of genotyping | Health care providers | Clinical research |
Transfusion-related Epstein-Barr virus (EBV) infection: A multicenter prospective cohort study among pediatric recipients of hematopoietic stem cell transplants (TREASuRE study) | Enok Bonong PR, Buteau C, Delage G, Tanner JE, Lacroix J, Duval M, Laporte L, Tucci M, Robitaille N, Spinella PC, Cuvelier G, Vercauteren S, Lewis V, Fearon M, Drews SJ, Alfieri C, Trottier H | 2021 | Transfusion | View Transfusion-related Epstein-Barr virus (EBV) infection: A multicenter prospective cohort study among pediatric recipients of hematopoietic stem cell transplants (TREASuRE study) | Health care providers | Clinical research |
Circular of information for the use of human blood components: Plasma Components | Stewart T | 2022 | Blood.ca website | View Circular of information for the use of human blood components: Plasma Components | Health care providers | Benchmarking and standard setting |
Performance characteristics of platelet autoantibody testing for the diagnosis of immune thrombocytopenia using strict clinical criteria | Gabe C, Sirotich E, Li N, Ivetic N, Nazy I, Smith J, Kelton JG, Arnold DM | 2021 | Br J Haematol | View Performance characteristics of platelet autoantibody testing for the diagnosis of immune thrombocytopenia using strict clinical criteria | Health care providers | Clinical research |
The von Willebrand factor-binding aptamer rondaptivon pegol as a treatment for severe and nonsevere hemophilia A | Ay C, Kovacevic KD, Kraemmer D, Schoergenhofer C, Gelbenegger G, Firbas C, Quehenberger P, Jilma-Stohlawetz P, Gilbert JC, Zhu S, Beliveau M, Koenig F, Iorio A, Jilma B, Derhaschnig U, Pabinger I | 2023 | Blood | View The von Willebrand factor-binding aptamer rondaptivon pegol as a treatment for severe and nonsevere hemophilia A | Health care providers | Clinical research |
Chapter 17. Hemostatic disorders and hereditary angioedema | Poon MC, Goodyear D, Rydz N, Lee A | 2022 | Clinical Guide to Transfusion | View Chapter 17. Hemostatic disorders and hereditary angioedema | Health care providers | Benchmarking and standard setting |
Approach to the diagnosis and management of drug-induced immune thrombocytopenia | Arnold DM, Nazi I, Warkentin TE, Smith JW, Toltl LJ, George JN, Kelton JG | 2013 | Transfus Med Rev | View Approach to the diagnosis and management of drug-induced immune thrombocytopenia | Health care providers | Clinical research |
Clinical effectiveness of a Bayesian algorithm for the diagnosis and management of heparin-induced thrombocytopenia | Raschke RA, Gallo T, Curry SC, Whiting T, Padilla-Jones A, Warkentin TE, Puri A | 2017 | J Thromb Haemost | View Clinical effectiveness of a Bayesian algorithm for the diagnosis and management of heparin-induced thrombocytopenia | Health care providers | Clinical research |
Donor deferral policies for men who have sex with men: past, present and future | Goldman M, Shih AW, O'Brien SF, Devine D | 2018 | Vox Sang | View Donor deferral policies for men who have sex with men: past, present and future | Health care providers | MSM research |
Heparin-induced thrombocytopenia | Greinacher A, Warkentin T | 2017 | Practical Transfusion Medicine, 5th Edition | View Heparin-induced thrombocytopenia | Health care providers | Clinical research |
IV immunoglobulin for autoimmune heparin-induced thrombocytopenia | Ning S, Warkentin TE | 2017 | Chest | View IV immunoglobulin for autoimmune heparin-induced thrombocytopenia | Health care providers | Clinical research |
Massive hemorrhage and emergency transfusion | Trudeau J | 2017 | Clinical Guide to Transfusion | View Massive hemorrhage and emergency transfusion | Health care providers | Benchmarking and standard setting |
Nonheparin anticoagulants for heparin-induced thrombocytopenia | Kelton JG, Arnold DM, Bates SM | 2013 | N Engl J Med | View Nonheparin anticoagulants for heparin-induced thrombocytopenia | Health care providers | Clinical research |
Pre-operative autologous donation | Pambrun C | 2017 | Clinical Guide to Transfusion | View Pre-operative autologous donation | Health care providers | Benchmarking and standard setting |
Splenectomy for immune thrombocytopenia: down but not out | Chaturvedi S, Arnold DM, McCrae KR | 2018 | Blood | View Splenectomy for immune thrombocytopenia: down but not out | Health care providers | Clinical research |
Transfusion Patterns in All Patients Admitted to the Intensive Care Unit and in Those Who Die in Hospital: A Descriptive Analysis | Shehata N, Forster AJ, Lawrence N, Ducharme R, Fergusson DA, Chassé M, Rothwell DM, Hébert PC, Tinmouth AT, Wilson K | 2015 | PLoS One | View Transfusion Patterns in All Patients Admitted to the Intensive Care Unit and in Those Who Die in Hospital: A Descriptive Analysis | Health care providers | Clinical research |
Massive hemorrhage protocol survey: Marked variability and absent in one-third of hospitals in Ontario, Canada | Chin V, Cope S, Yeh CH, Thompson T, Nascimento B, Pavenski K, Callum J | 2019 | Injury | View Massive hemorrhage protocol survey: Marked variability and absent in one-third of hospitals in Ontario, Canada | Health care providers | Clinical research |
Blood coagulation dissected | Pryzdial ELG, Lee FMH, Lin BH, Carter RLR, Tegegn TZ, Belletrutti MJ | 2018 | Transfus Apher Sci | View Blood coagulation dissected | Health care providers | Other |
Serologic assessments in acute transfusion reactions: practices and yields | Cohen R, Lima A, Escorcia A, Tasmin F, Lin Y, Lieberman L, Pendergrast J, Callum J, Cserti-Gazdewich C | 2019 | Vox Sang | View Serologic assessments in acute transfusion reactions: practices and yields | Health care providers | Clinical research |
Exploring the frontiers of IVIG-associated hemolysis | Pendergrast J, Branch D | 2020 | Blood.ca website | View Exploring the frontiers of IVIG-associated hemolysis | Health care providers | Benchmarking and standard setting |
A user guide to the American Society of Hematology clinical practice guidelines | Izcovich A, Cuker A, Kunkle R, Neumann I, Panepinto J, Pai M, Seftel M, Cheung MC, Lottenberg R, Byrne M, Plovnick R, Terrell D, Holter-Chakrabarty JL, Djulbegovic B, Hicks LK, Wiercioch W, Nieuwlaat R, Schünemann HJ | 2020 | Blood Adv | View A user guide to the American Society of Hematology clinical practice guidelines | Health care providers | Benchmarking and standard setting |
Acute thrombocytopenia suggesting thrombotic microangiopathy | Venier LM, Patriquin CJ, Warkentin TE | 2022 | Am J Hematol | View Acute thrombocytopenia suggesting thrombotic microangiopathy | Health care providers | Clinical research |
Recognizing, managing and reporting vaccine-induced immune thrombotic thrombocytopenia | Sholzberg M, Arnold DM, Laupacis A | 2021 | CMAJ | View Recognizing, managing and reporting vaccine-induced immune thrombotic thrombocytopenia | Health care providers | Clinical research |
Impact of COVID-19 on blood donation in Canada | Khandelwal A | 2021 | Blood.ca website | View Impact of COVID-19 on blood donation in Canada | Health care providers | Benchmarking and standard setting |